Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
CURRENT ASSETS:
Cash and cash equivalents	$ 16,148	$ 17,703
Accounts receivable, net of allowance for credit losses of $2,315 and $3,225 at 2022 and 2021, respectively	99,180	96,830
Inventories	52,551	45,443
Prepaid expenses	14,252	14,059
Income taxes receivable	12,319	9,911
Other current assets	5,171	5,109
TOTAL CURRENT ASSETS	199,621	189,055
PROPERTY, PLANT AND EQUIPMENT, net of accumulate depreciation of $309,804 and $306,461 at 2022 and 2021, respectively	109,176	110,952
RIGHT OF USE ASSETS	57,964	61,387
INTANGIBLES, net of accumulated amortization of $17,251 and $17,540 at 2022 and 2021, respectively	7,837	8,139
GOODWILL	99,445	99,445
DEFERRED TAX ASSETS, net	68,918	70,462
OTHER ASSETS	34,579	41,413
TOTAL ASSETS	577,540	580,853
CURRENT LIABILITIES:
Accounts payable	36,106	29,726
Accrued payroll and related costs	22,830	20,833
Taxes other than payroll and income	6,453	5,931
Unearned revenues	6,527	7,765
Operating lease liabilities	13,008	12,342
Income taxes payable	3,436	6,502
Other current liabilities	7,549	7,683
TOTAL CURRENT LIABILITIES	95,909	90,782
LONG-TERM DEBT, net	186,979	188,636
LONG-TERM OPERATING LEASE LIABILITIES	44,231	49,286
DEFERRED COMPENSATION	31,646	39,101
DEFERRED TAX LIABILITIES, net	23,322	24,336
OTHER LONG-TERM LIABILITIES	21,686	27,711
COMMITMENTS AND CONTINGENCIES
EQUITY:
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	0	0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 46,454,264 issued and 46,324,807 outstanding at 2022 and 46,454,264 issued and 46,349,397 outstanding at 2021	1,188	1,188
Additional paid-in capital	104,779	101,120
Retained earnings	72,601	68,349
Accumulated other comprehensive income (loss)	(4,749)	(10,133)
Treasury shares (at cost), 129,457 at 2022 and 104,867 at 2021	(4,682)	(4,075)
Total Core Laboratories N.V. shareholders' equity	169,137	156,449
Non-controlling interest	4,630	4,552
TOTAL EQUITY	173,767	161,001
TOTAL LIABILITIES AND EQUITY	$ 577,540	$ 580,853